Opinion: Beyond Partisanship in Biopolitics

Concerns about the relationship between science and society transcend traditional political differences.

Written byMatthew C. Nisbet and Ezra M. Markowitz
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, HORIA VARLANDuring the next decade, advances in the life sciences are likely to generate intense political debate in the United States and around the world. Even as conflict over human embryonic stem cell (hESC) research has largely subsided, controversies may resurface as such investigations move forward, and as political conditions change. High-profile debates at the national and local levels over synthetic biology, personal genomics, and various reproductive technologies may also emerge.

Public discussion is likely to focus on a recurring set of questions that blur traditional partisan and ideological differences: Do scientific breakthroughs promote or undermine social progress? Is research being pursued too cautiously or too quickly? Do scientists respect or cross moral boundaries? Does research serve the public interest or private interests?

In a study we published this week (February 18) in PLOS ONE, we analyzed a series of nationally representative surveys collected between 2002 and 2010 with the goal of better understanding how the U.S. public came to form opinions and judgments about embryonic stem cell research. The intense campaigning on the issue across elections and states allowed for a unique retrospective comparison of the major factors that shaped public opinion. We used a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies